We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 18

Bristol-Myers Squibb Canada Co. et al v. Mylan Pharmaceuticals ULC et al, 2012 FC 1142 (September 27, 2012) efavirenz PM(NOC) case
  • Gowling WLG
  • USA
  • September 27 2012

This proceeding brought by Bristol-Myers Squibb Canada Co. and Merck Sharpe & Dohme Corp. (“Applicants”) under the Patented Medicines (Notice of Compliance) Regulations dealt with two patents related to the Applicants’ SUSTIVA (efavirenz) product.


Conflicts of interest in complex investment structures - the evolution of the business judgment rule
  • Gowling WLG
  • USA, Canada
  • June 19 2012

Gowlings recently hosted a seminarwebinar for clients of our firm entitled The Business Judgment RuleFiduciary Duties Arising From Administration of Assets and For Approving Transactions.


Elisa Scali
  • Gowling WLG

Scott E. Foster
  • Gowling WLG



Evan Atwood
  • Gowling WLG

Alice Stagg
  • Gowling WLG


Jeff Beedell
  • Gowling WLG